The relationship of baseline fasting plasma glucose and cardiovascular morbidity and mortality

      It is clear that diabetes has strong implications for cardiovascular morbidity and mortality, although an increasing number of studies have suggested that fasting plasma glucose (FPG) values below the diabetes (and prediabetes) threshold also contribute to increased cardiovascular risk. A body of evidence exists supporting the idea that FPG values even lower than 100 mg/dL are associated with an increased risk of cardiovascular morbidity and mortality, after accounting for other variables.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • DeFronzo R.A.
        • Abdul-Ghani M.
        Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.
        Am J Cardiol. 2011; 108: 3B-24B
        • Genuth S.
        • Alberti K.G.
        • Bennett P.
        • et al.
        Expert committee on the diagnosis and classification of diabetes mellitus 2, the expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus.
        Diabetes Care. 2003; 26: 3160-3167
        • Nichols G.A.
        • Hillier T.
        • Brown J.B.
        Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
        Am J Med. 2008; 121: 519-524
        • Shaw J.E.
        • Zimmet P.Z.
        • Hodge A.M.
        • et al.
        Impaired fasting glucose: how low should it go?.
        Diabetes Care. 2000; 23: 34-39
        • Shaye K.
        • Amir T.
        • Shlomo S.
        • Yechezkel S.
        Fasting glucose levels within the high normal range predict cardiovascular outcome.
        Am Heart J. 2012; 164: 111-116
        • Khaw K.T.
        • Wareham N.
        • Bingham S.
        • Luben R.
        • Welch A.
        • Day N.
        Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
        Ann Intern Med. 2004; 141: 413-420
        • Garg N.
        • Moorthy N.
        • Kapoor A.
        • et al.
        Hemoglobin a 1c in nondiabetic patients: an independent predictor of coronary artery disease and its severity.
        Mayo Clin Proc. 2014; 89: 908-916
        • Selvin E.
        • Coresh J.
        • Golden S.H.
        • Brancati F.L.
        • Folsom A.R.
        • Steffes M.W.
        Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study.
        Arch Intern Med. 2005; 165: 1910-1916
        • Scicali R.
        • Giral P.
        • Gallo A.
        HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
        Atherosclerosis. 2016; 255: 102-108